Keywords: altana, beats, forecasts, profit, rise, german, drugmaker
Altana beats forecasts with 7% profit rise
Article | 09 August 2004
German drugmaker Altana AG has posted strong first-half 2004 resultsthat beat consensus analysts' forecasts. Sales were up 9% to 1.5 billion euros ($1.81 billion), ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
